Skip to main content
Clinical Trials/ITMCTR2000003916
ITMCTR2000003916RecruitingPhase 1

A randomized controlled clinical study of Feng's steam therapy in the treatment of dyslipidemia

Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
18 to 75 (—)
Sex
All

Inclusion Criteria

  • (1) Meet the diagnostic criteria of Western medicine for hypercholesterolemia or mixed hyperlipidemia;
  • (2) TCM differentiation is the syndrome of damp turbid arthralgia;
  • (3) Aged over 18 and under 75;
  • (4) Sign the informed consent form.

Exclusion Criteria

  • (1) Patients who have suffered from acute myocardial infarction, cerebrovascular accident, severe trauma, post-PCI or other major surgery within six months and need to take lipid-lowering drugs for a long time;
  • (2) Patients with acute coronary syndrome;
  • (3) Those with secondary hyperlipidemia caused by nephrotic syndrome, hypothyroidism, gout, acute or chronic hepatobiliary disease, diabetes, etc.;
  • (4) Hyperlipidemia caused by drugs (phenothiazines, ß-receptor blockers, adrenal corticosteroids, and certain contraceptives, etc.) or who are using heparin, thyroxine therapy drugs and other drugs that affect blood lipid metabolism patient;
  • (5) Combined with serious primary diseases such as liver, kidney and hematopoietic system;
  • (6) Pregnant or lactating women or those who plan to become pregnant during the trial period or whose spouse plans to become pregnant;
  • (7) Those who are allergic or may be allergic to this treatment;
  • (8) Patients with heart failure and heart function >= NYHA III; combined with severe arrhythmia (such as frequent ventricular premature, ventricular tachycardia, rapid atrial fibrillation, etc.) or other severe or unstable heart, liver, kidney, endocrine, Patients with medical diseases such as blood;
  • (9) Patients with uncontrolled grade 3 hypertension (sitting diastolic blood pressure >= 110mmHg or systolic blood pressure >= 180mmHg;
  • (10) People with mental illness, alcohol or drug dependence;
  • (11) Patients with liver and kidney damage, ALT >= 1.5N, Cr > 1N (N is the upper limit of normal);
  • (12) Those with a history of malignant tumors or related diseases;
  • (13) Subjects participated in other clinical trials within 1 month;
  • (14) People with infectious skin diseases or skin injuries;
  • (15) Any other situation that the investigator believes will affect the efficacy and safety of the trial drug treatment.

Investigators

Sponsor
Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences

Similar Trials